HERTART ApS: Financial statements 2022
CVR: 32840787
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
HERTART ApS (CVR 32840787) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 4,292,959 and a net result of DKK 3,356,076 compared with DKK 1,775,233 the year before. That is an increase of 87.9% compared with the year before. Equity in the 2022 report amounted to DKK 3,592,585. The solvency ratio was 73%.
- Gross Profit
- DKK 4,292,959
- Profit/Loss
- DKK 3,356,076
- Equity
- DKK 3,592,585
- Total Assets
- DKK 4,923,968
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 4.3 mio. | 3.4 mio. | 3.6 mio. | - |
| 2021 | - | 2.3 mio. | 1.8 mio. | 8 mio. | - |
| 2020 | - | 1 mio. | 1.1 mio. | 6.3 mio. | - |
| 2019 | - | 876 t. | 870 t. | 5.1 mio. | - |
| 2018 | - | 1.4 mio. | 1.4 mio. | 4.3 mio. | - |
Official annual report
Keep an eye on HERTART ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HERTART ApS has published its annual report for 2021. Gross profit came to DKK 2,284,953, and the net result was DKK 1,775,233.
As of May 31, 2022, Bo Lars Risberg has joined the board of directors of HERTART ApS.
As of May 31, 2022, Lars Peter Westrin has left the board of directors of HERTART ApS.
About HERTART ApS
HERTART ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Per Svensson. The board consists of Per Svensson, Ralf Piegsa and Tom Faes. The company is owned by Vitrolife AB. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK 3,212,963 and a net result of DKK 2,675,487 compared with DKK 3,485,182 the year before. Equity in the 2025 report amounted to DKK 11,349,671.